A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Non Small Cell Lung Cancer|Breast Cancer
Interventions: DRUG: YL202
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.